Biotech · Private company
Kowa Research Institute, Inc.
Track this companyFree. Adds Kowa Research Institute, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials221 recruiting or active
Pipeline programs29From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline29
- FenofibratePhase 3 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- K-161Phase 3 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- K-877Phase 3 · Type2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- K-877Phase 3 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- LivaloPhase 3 · HyperlipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- Livalo® IRPhase 3 · HyperlipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- NK-104-CRPhase 3 · HyperlipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- RipasudilPhase 3 · Corneal Edema After Cataract SurgeryClinicalTrials.gov · fetched Nov 12, 2026
- RipasudilPhase 3 · Fuchs Endothelial Corneal DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- CSG452Phase 2 · NASHClinicalTrials.gov · fetched Nov 12, 2026
- K-285Phase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- K-321 SolutionPhase 2 · Fuchs' Endothelial Corneal DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- K-808 (Dose A)Phase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- K-808 (Dose B)Phase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- K-877-ERPhase 2 · NASHClinicalTrials.gov · fetched Nov 12, 2026
- K-877-ER (Dose A)Phase 2 · DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- K-877-ER (Dose B)Phase 2 · DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- K-877-IRPhase 2 · DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- MentholPhase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- CSG452Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- IndomethacinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- K-001Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- K-285Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- K-808Phase 1 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
- K-877Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- K-877-ERPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- KI-362-US1 (YP2.2VM)Aphakia, PostcataractClinicalTrials.gov · fetched Nov 12, 2026
- Lopinavir/ritonavirHealthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Pitavastatin (NK-104)Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials22
- Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract ExtractionNA · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07650201 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.PHASE1 · COMPLETED · started Oct 1, 2024ClinicalTrials.gov NCT06525311 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.PHASE2 · COMPLETED · started Feb 7, 2024ClinicalTrials.gov NCT06247735 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)PHASE3 · COMPLETED · started May 11, 2023ClinicalTrials.gov NCT05826353 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)PHASE3 · COMPLETED · started Mar 30, 2023ClinicalTrials.gov NCT05795699 · fetched Nov 12, 2026
- Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452PHASE1 · COMPLETED · started Feb 24, 2023ClinicalTrials.gov NCT05722262 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisPHASE2 · COMPLETED · started Nov 14, 2022ClinicalTrials.gov NCT05327127 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract SurgeryPHASE3 · COMPLETED · started Aug 4, 2022ClinicalTrials.gov NCT05528172 · fetched Nov 12, 2026
- A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye DiseasePHASE3 · COMPLETED · started Jul 3, 2022ClinicalTrials.gov NCT05403827 · fetched Nov 12, 2026
- Study to Assess the Food Effect of K-877 in Healthy Adult VolunteersPHASE1 · COMPLETED · started Jan 13, 2021ClinicalTrials.gov NCT04742218 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower ExtremityPHASE2 · TERMINATED · started Aug 15, 2020ClinicalTrials.gov NCT04484428 · fetched Nov 12, 2026
- Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following DescemetorhexisPHASE2 · COMPLETED · started Jun 23, 2020ClinicalTrials.gov NCT04250207 · fetched Nov 12, 2026
- Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IRPHASE2 · COMPLETED · started Jun 10, 2020ClinicalTrials.gov NCT04447820 · fetched Nov 12, 2026
- Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult VolunteersPHASE1 · COMPLETED · started Dec 17, 2019ClinicalTrials.gov NCT04237597 · fetched Nov 12, 2026
- A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseasePHASE2 · COMPLETED · started Aug 4, 2019ClinicalTrials.gov NCT04084483 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy AdultsPHASE1 · COMPLETED · started Oct 4, 2018ClinicalTrials.gov NCT03712241 · fetched Nov 12, 2026
- Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)PHASE3 · TERMINATED · started Mar 23, 2017ClinicalTrials.gov NCT03071692 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal FunctionPHASE3 · COMPLETED · started Nov 28, 2016ClinicalTrials.gov NCT03001817 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal ImpairmentPHASE3 · COMPLETED · started Nov 26, 2016ClinicalTrials.gov NCT03011450 · fetched Nov 12, 2026
- Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed DyslipidemiaPHASE3 · WITHDRAWN · started Feb 1, 2016ClinicalTrials.gov NCT02799758 · fetched Nov 12, 2026
- Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed DyslipidemiaPHASE3 · WITHDRAWN · started Jan 1, 2016ClinicalTrials.gov NCT02670434 · fetched Nov 12, 2026
- Drug-Drug Interaction of Lopinavir/Ritonavir on PitavastatinPHASE4 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01057433 · fetched Nov 12, 2026